Follow
eiman mukhtar
eiman mukhtar
Research scientist, Weill Cornell Medicine
Verified email at med.cornell.edu
Title
Cited by
Cited by
Year
Targeting microtubules by natural agents for cancer therapy
E Mukhtar, VM Adhami, H Mukhtar
Molecular cancer therapeutics 13 (2), 275-284, 2014
5922014
Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents
E Mukhtar, V Mustafa Adhami, N Khan, H Mukhtar
Current drug targets 13 (14), 1831-1841, 2012
1052012
Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells
E Mukhtar, VM Adhami, M Sechi, H Mukhtar
Cancer letters 367 (2), 173-183, 2015
642015
Fisetin enhances chemotherapeutic effect of cabazitaxel against human prostate cancer cells
E Mukhtar, VM Adhami, IA Siddiqui, AK Verma, H Mukhtar
Molecular cancer therapeutics 15 (12), 2863-2874, 2016
402016
Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells
N Khan, F Jajeh, MI Khan, E Mukhtar, SM Shabana, H Mukhtar
Carcinogenesis 38 (2), 184-195, 2017
282017
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
S Kim, CMC Au, MAB Jamalruddin, NE Abou-Ghali, E Mukhtar, L Portella, ...
Elife 11, e73396, 2022
102022
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with …
E Mukhtar, D Worroll, G Galletti, S Schuster, SA Piha-Paul, ...
Cancer Drug Resistance 3 (3), 636, 2020
92020
IOP Conference Series: Materials Science and Engineering
A Sara Qaisar, N Khan, EA Mukhtar
Institute of Physics: London, UK 146, 012025, 2016
92016
Synthesis of the Deacetoxytubuvaline Fragment of Pretubulysin and its Lipophilic Analogues for Enhanced Permeability in Cancer Cell Lines
RB Reddy, P Dudhe, V Chelvam
Synlett 30 (01), 77-81, 2019
22019
Fisetin enhances the efficacy of cabazitaxel: an in vitro and in vivo study in prostate cancer
E Mukhtar, VM Adhami, M Sechi, H Mukhtar
Cancer Research 75 (15_Supplement), 2531-2531, 2015
12015
Fisetin enhances the efficacy of cabazitaxel chemotherapy in prostate metastatic and multidrug-resistant cancer cells
E Mukhtar, VM Adhami, H Mukhtar
Cancer Research 74 (19_Supplement), 835-835, 2014
12014
Botanical antioxidants for photochemoprevention
E Mukhtar, V Adhami, H Mukhtar
Handbook of photomedicine, 167-176, 2013
12013
Fisetin, a dietary flavonoid, binds to and disrupts microtubule dynamic instability in prostate cancer cells.
E Mukhtar, VM Adhami, DN Syed, H Mukhtar
Cancer Research 73 (8_Supplement), 4495-4495, 2013
12013
Analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRLX301, a …
E Mukhtar, D Worroll, G Galletti, S Schuster, SA Piha-Paul, ...
Cancer Research 80 (16), 2020
2020
Novel inhibitors of AR-v7 nuclear import: new therapeutic opportunities for CRPC
S Kim, MA Jamalruddin, E Mukhtar, M Miller, L Baxt, S Kargman, ...
Cancer Research 79 (13_Supplement), 1017-1017, 2019
2019
Characterization of molecular mechanisms of cytoplasmic trafficking and nuclear translocation of AR splice variants ARv7
E Mukhtar, S Kim, P Giannakakou
Cancer Research 77 (13_Supplement), 5634-5634, 2017
2017
Combined treatment of fisetin and cabazitaxel significantly inhibits tumor growth and metastasis of prostate cancer cells
E Mukhtar, VM Adhami, IA Siddiqui, H Mukhtar
Cancer Research 76 (14_Supplement), 621-621, 2016
2016
Cucurbitacin B targets EGFR-mutant lung cancer cells via activation of sestrin-3
N Khan, F Jajeh, MI Khan, E Mukhtar, H Mukhtar
Cancer Research 76 (14_Supplement), 3763-3763, 2016
2016
Fisetin, a dietary flavonoid, binds to β-tubulin, and disrupts microtubule dynamics in prostate cancer cells
E Mukhtar
The University of Wisconsin-Madison, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–19